Clin2
NCT06408181Likely a fitRecruiting

Aspirin to prevent pregnancy loss and preeclampsia

Pre-EclampsiaPregnancy Loss

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,150 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are 18 to 45 years old and less than 7 weeks pregnant.
  • You have at least one risk factor for preeclampsia or pregnancy loss (like a previous miscarriage, high blood pressure, diabetes, age 35+, or carrying twins).
  • You are not allergic to aspirin or anti-inflammatory medicines.
  • You do not have a bleeding disorder, stomach ulcer, or need blood thinners.
  • You are willing to take a daily aspirin pill and follow the study schedule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04356326Recruiting· Phase 3
Aspirin to prevent complications in pregnancy with chronic high blood pressure

This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.

Bordeaux
NCT05625724Recruiting· Phase 3
Aspirin to help prevent pregnancy complications after IVF

This Phase 3 study tests whether daily low-dose aspirin can reduce the risk of preeclampsia (dangerous high blood pressure in pregnancy) and improve pregnancy outcomes for people who got pregnant using assisted reproduction like IVF. It mainly targets pregnancies early on (about 9–14 weeks).

Angers
NCT03667326Recruiting· Phase 2
Low-dose aspirin after severe preeclampsia

This Phase 2 study tests whether starting low-dose aspirin after delivery can help people who had severe preeclampsia. The goal is to see if this treatment is safe and beneficial in the weeks after birth.

New York, New York
NCT05709483Recruiting· Early Phase 1
Aspirin plan test to predict who avoids preeclampsia

This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.

New York, New York
NCT06826859Recruiting· Phase 1/Phase 2
Daily aspirin vs split dosing to prevent preeclampsia

This study compares taking a daily low-dose aspirin (a single pill) versus splitting the same dose into two smaller pills many hours apart to see which way better prevents preeclampsia in pregnant people who are at higher risk.

Philadelphia, Pennsylvania
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna

Hear when a new Pre-Eclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.